Cara Therapeutics | CARA - Pe Kurs-Gewinn

Aktienkurs
4.00
Täglich Wechseln
0.04 1.01%
Monatlich
24.22%
Jährlich
-84.15%
Q2 Prognose
4.09




Pe Veränderung Datum
Acadia Pharmaceuticals 10.08 1.53 2026-03
Cara Therapeutics 27.77 117.09 2021-09
Chugai Pharma 28.87 2.38 2026-03
Cipla 27.74 3.55 2025-12
Clal Biotechnology 11.67 2.62 2022-12
Compugen 4.06 75.75 2025-12
CSL 16.16 9.59 2025-12
Grifols 11.2 1.08 2025-12
Halozyme Therapeutics 11.35 11.8 2026-03
J&J 24.53 0.91 2026-03
Neurocrine Biosciences 28.09 807.38 2026-03
Pacira 38.58 14.1 2026-03
Pfizer 9.32 5.16 2026-03
RedHill Biopharma 0.04 0.03 2025-06
Supernus Pharmaceuticals 44.21 66.17 2026-03
Vanda Pharmaceuticals 16.79 7.07 2023-06